Media Release
NEST officially declared collaboration with DKSH, DiethelmKellerSiberHegner, specializing in market expansion services for products distribution in Australia, Indonesia, New Zealand, the Philippines, Singapore, Thailand, and Vietnam.
On June 8, 2022, NEST declared collaboration with DKSH , DiethelmKellerSiberHegner, specializing in market expansion services for products distribution in Australia, Indonesia, New Zealand, the Philippines, Singapore, Thailand, and Vietnam, in a bid to expand markets coverage in Asia Pacific. NEST has reached various points of consensus with DKSH and authorized it proper rights to distribute NEST's various biotech products collections of scientific research consumables, pharmaceutical packaging, and medical consumables. This strategic business collaboration offers both two companies a great opportunity of in-depth face-to face communication as well as a huge challenge for market expansion. NEST will firmly stick to the principle of faithfulness, pragmatism, integrity and cooperation in the close cooperation with DKSH and ready to secure stable and high-quality plastic laboratory consumables for clients in Asia Pacific region.
DKSH, also known as DiethelmKellerSiberHegner,a Swiss holding company ingrained communities all across the Asia Pacific region, offers any combination of sourcing, marketing, sales, distribution and after-sales-services and is organized into four Business Units: Consumer Goods (including the Business Segment Luxury & Lifestyle), Healthcare, Performance Materials and Technology. Its core business is supporting other companies to grow their business in new or existing market.
Frank Liu, Oversea Sales Manager, expressed NEST's outlook as follows, “DKSH offers great market coverage in Southeast Asia and has a strong focus in the life sciences segment. We believe that DKSH is the right partner to help us expand the business, penetrate the cell culture market, and meet our growth goals,”
The Senior Director, Business Development, Business Unit Technology of DKSH, Marco Farina commented: "Expanding our life sciences portfolio and accelerating our growth for the consumable business are key initiatives for DKSH Technology. Partnering with Wuxi Nest Biotechnology complements our product portfolio. We are excited to introduce Wuxi Nest Biotechnology’s leading products to our customers.”
About DKSH
DKSH's purpose is to enrich people's lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, e-Commerce, distribution and logistics as well as after-sales services. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 32,450 specialists, generating net sales of CHF 10.7 billion in 2020. www.dksh.com
